Soteropoulos Paula
CIK 0001692444
Director
Filings
19
Latest May 22, 2026
Issuers covered
3
Showing
19 of 19
Page 1
Track record
7 of 8 open-market trades scored (88% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 43% | -6.1% | -4.6% | +45.2% | -73.5% |
| 90 days | 5 | 80% | +18.6% | +12.7% | +60.6% | -4.2% |
| 180 days | 5 | 60% | -7.4% | +51.9% | +60.2% | -191.4% |
| 365 days | 5 | 60% | +0.6% | +67.9% | +75.9% | -192.2% |
Issuers
Companies where Soteropoulos Paula has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /De/ | 7 | May 22, 2026 |
| QURE | Uniqure N.V. | 7 | Jun 17, 2024 |
| RLYB | Rallybio Corp | 5 | May 15, 2025 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|